内镜下经鼻手术治疗垂体腺瘤:使用不同二维和三维可视化系统的手术病例系列治疗结果
该病例系列分析了2008年12月至2017年12月间170例原发性垂体腺瘤患者,分别使用二维高清、三维标准、三维高清内镜经鼻手术,比较肿瘤大小、切除率、并发症及内分泌眼科结果。三维高清组完全切除率80%,三维标准组72%,二维高清组72%,三组间无显著差异;新发垂体功能低下率三维高清组4.8%,二维高清组16.6%,三维标准组12%,P=0.290。
要点
- 三组完全切除率分别为三维高清80%、三维标准72%、二维高清72%,无显著差异。
- 并发症数量三组间无差异(P=0.436)。
- 新发垂体功能低下率三维高清组4.8%,二维高清组16.6%,三维标准组12%,P=0.290。
核心结论
- 尽管三维高清组切除率更高且三维高清内镜有主观优势,但三组在完全切除或新发激素缺陷方面无显著差异。
研究设计与样本
- 研究分析了2008年12月至2017年12月间手术治疗的初发垂体腺瘤患者数据,比较术前术后肿瘤大小和位置、围手术期并发症及眼科、内分泌和临床结果。
主要发现
- 共170例患者接受内镜下初发垂体腺瘤切除,其中二维高清组54例,三维标准组75例,三维高清组41例。
- 术前肿瘤大小、扩展范围及内分泌和眼科状态三组间无统计学差异。
- 肿瘤切除程度三组间无统计学差异,三维高清组完全切除33例(80%),三维标准组54例(72%),二维高清组39例(72%)。
- 并发症数量三组间无差异(P=0.436),眼科结果不因内镜技术而异。
- 新发垂体功能低下率三维高清组略低于二维高清组和三维标准组(分别为4.8%、16.6%和12%;P=0.290)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Endoscopic endonasal transsphenoidal surgery (EETS) is a common treatment for patients with pituitary adenomas (PAs). A disadvantage of endoscopic surgery has been the lack of stereoscopic vision and depth perception. Recent developments offer high-definition 3-dimensional (3D-HD) visualization with a higher resolution and better image quality compared with 3D standard endoscopy (3D-SD). In this study, we compared treatment results of surgically treated patients with PAs using 3 different visualization systems: 2-dimensional (2D)-HD, 3D-SD, and 3D-HD. METHODS: Data from patients with primary PAs that were surgically treated between December 2008 and December 2017 were analyzed. Preoperative and postoperative tumor size and location, perioperative complications, and ophthalmologic, endocrine, and clinical outcomes were compared. RESULTS: A total of 170 patients underwent endoscopic resection of a primary PA (54 patients with 2D-HD, 75 with 3D-SD, and 41 with 3D-HD). Preoperatively, no statistical differences were found for tumor size, extension, and endocrine and ophthalmologic status. Tumor resection was not statistically different among the 3 groups. Complete resection was performed in 33 patients (80%) in the 3D-HD group, 54 patients (72%) in the 3D-SD group, and 39 patients (72%) in the 2D-HD group. The number of complications was not different across the groups (P = 0.436). Ophthalmologic outcomes did not differ based on EETS technique. The rate of new pituitary insufficiency was slightly lower in the 3D-HD group compared with 2D-HD and 3D-SD groups (4.8%, 16.6%, and 12%, respectively; P = 0.290). CONCLUSIONS: Although the resection rate was higher in the 3D-HD group, and subjective advantages of the 3D-HD endoscopes were noted, there were no significant differences in terms of gross total resection or new hormonal deficits among the 3 groups.
引用
- Hajdari S, Kellner G, Meyer A, et al. Endoscopic Endonasal Surgery for Removal of Pituitary Adenomas: A Surgical Case Series of Treatment Results Using Different 2- and 3-Dimensional Visualization Systems. World Neurosurg. 2018. PMID: 30010078. doi:10.1016/j.wneu.2018.07.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。